Published in Hum Vaccin Immunother on February 22, 2016
Parents' Support for School-Entry Requirements for Human Papillomavirus Vaccination: A National Study. Cancer Epidemiol Biomarkers Prev (2016) 0.81
Human Papillomavirus and Mandatory Immunization Laws: What Can We Learn From Early Mandates? Public Health Rep (2016) 0.78
Adolescent Human Papillomavirus Vaccination in the United States: Opportunities for Integrating Pharmacies into the Immunization Neighborhood. Hum Vaccin Immunother (2017) 0.75
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA (2009) 5.58
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med (2009) 4.12
Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr (2014) 3.77
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med (2000) 3.65
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014. MMWR Morb Mortal Wkly Rep (2015) 3.48
Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis (2011) 3.39
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer (2008) 3.16
Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev (2009) 3.07
Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine (2010) 3.06
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine (2011) 2.43
Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev (2009) 1.74
HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr (2011) 1.72
Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) (2012) 1.46
Childhood immunization: laws that work. J Law Med Ethics (2002) 1.44
HPV vaccination mandates--lawmaking amid political and scientific controversy. N Engl J Med (2010) 1.43
The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol (2007) 1.37
Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine (2012) 1.33
HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care (2014) 1.31
Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines (2014) 1.26
Physician communication about adolescent vaccination: How is human papillomavirus vaccine different? Prev Med (2015) 1.23
Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics (2012) 1.23
Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine (2013) 1.13
Population impact of HPV vaccines: summary of early evidence. J Adolesc Health (2013) 1.12
A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health (2004) 1.12
Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol (2013) 1.06
Physician response to parental requests to spread out the recommended vaccine schedule. Pediatrics (2015) 0.99
A comparative analysis of mandated benefit laws, 1949-2002. Health Serv Res (2006) 0.96
Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate. J Adolesc Health (2010) 0.89
Acceptability of school requirements for human papillomavirus vaccine. Hum Vaccin (2011) 0.85
Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, California. Cancer Epidemiol Biomarkers Prev (2011) 0.85
Mandatory HPV vaccination. JAMA (2012) 0.79
Australian HPV vaccination programme yields results. Lancet Oncol (2014) 0.77
Perceptions of personal belief vaccine exemption policy: a survey of Arizona vaccine providers. Vaccine (2014) 0.77